Cargando…
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319896/ https://www.ncbi.nlm.nih.gov/pubmed/34324159 http://dx.doi.org/10.1007/s12026-021-09212-5 |
| _version_ | 1783730543934832640 |
|---|---|
| author | Benucci, Maurizio Damiani, Arianna Infantino, Maria Manfredi, Mariangela Grossi, Valentina Lari, Barbara Gobbi, Francesca Li Sarzi-Puttini, Piercarlo |
| author_facet | Benucci, Maurizio Damiani, Arianna Infantino, Maria Manfredi, Mariangela Grossi, Valentina Lari, Barbara Gobbi, Francesca Li Sarzi-Puttini, Piercarlo |
| author_sort | Benucci, Maurizio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8319896 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83198962021-07-29 Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab Benucci, Maurizio Damiani, Arianna Infantino, Maria Manfredi, Mariangela Grossi, Valentina Lari, Barbara Gobbi, Francesca Li Sarzi-Puttini, Piercarlo Immunol Res Letter to the Editor Springer US 2021-07-29 2021 /pmc/articles/PMC8319896/ /pubmed/34324159 http://dx.doi.org/10.1007/s12026-021-09212-5 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Benucci, Maurizio Damiani, Arianna Infantino, Maria Manfredi, Mariangela Grossi, Valentina Lari, Barbara Gobbi, Francesca Li Sarzi-Puttini, Piercarlo Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab |
| title | Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab |
| title_full | Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab |
| title_fullStr | Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab |
| title_full_unstemmed | Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab |
| title_short | Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab |
| title_sort | presence of specific t cell response after sars-cov-2 vaccination in rheumatoid arthritis patients receiving rituximab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319896/ https://www.ncbi.nlm.nih.gov/pubmed/34324159 http://dx.doi.org/10.1007/s12026-021-09212-5 |
| work_keys_str_mv | AT benuccimaurizio presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab AT damianiarianna presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab AT infantinomaria presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab AT manfredimariangela presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab AT grossivalentina presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab AT laribarbara presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab AT gobbifrancescali presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab AT sarziputtinipiercarlo presenceofspecifictcellresponseaftersarscov2vaccinationinrheumatoidarthritispatientsreceivingrituximab |